BTK and B-cell chronic lymphocytic leukemia: Given the differences in expression of 14q32 cluster miRNAs and PTEN in Aca-R and IB-R CLL and DLBCL cells in vitro, we tested whether miRNA expression might also be altered in patient-derived primary CLL cells, in response to BTK inhibition or standard-of-care clinical therapy.